- Home
- TKNO
TKNO
Alpha Teknova Inc.
as of 11-28-2025 12:29pm EST
$4.65
$0.10
-2.11%
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
Chart Type:
Time Range:
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | HOLLISTER |
| Market Cap: | 236.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 200.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.94 - $10.37 | Next Earning Date: | 11-06-2025 |
| Revenue: | $39,801,000 | Revenue Growth: | 9.50% |
| Revenue Growth (this year): | 9.52% | Revenue Growth (next year): | 15.20% |
AI-Powered TKNO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 74.48%
74.48%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Alpha Teknova Inc. News
TKNO Breaking Stock News: Dive into TKNO Ticker-Specific Updates for Smart Investing
Compare TKNO vs Leading Stocks
See how TKNO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TKNO Alpha Teknova Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.